Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of topical ruxolitinib cream for hidradenitis suppurativa, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: RECRUITING